Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousLiver TransplantationBone Marrow TransplantationKidney TransplantationTransplantation ConditioningStem Cell TransplantationHeart TransplantationGraft SurvivalMultiple MyelomaLung TransplantationTreatment OutcomeCell TransplantationPeripheral Blood Stem Cell TransplantationMelphalanCombined Modality TherapyHematopoietic Stem Cell MobilizationOrgan TransplantationBlood Transfusion, AutologousGraft vs Host DiseaseGraft RejectionRecurrenceLymphoma, Non-HodgkinPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsSalvage TherapyBone Marrow PurgingTransplantation ImmunologyWhole-Body IrradiationAntigens, CD34TransplantationImmunosuppressive AgentsCyclophosphamideRetrospective StudiesCarmustineAntineoplastic Combined Chemotherapy ProtocolsRemission InductionTime FactorsTransplantation ChimeraSurvival AnalysisHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorLeukapheresisHematologic NeoplasmsDisease-Free SurvivalBusulfanSurvival RateTransplantation, IsogeneicFollow-Up StudiesEtoposideHodgkin DiseaseLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationCytarabineHeart-Lung TransplantationMyeloablative AgonistsImmunosuppressionGraft vs Tumor EffectTransplantation ToleranceTissue and Organ ProcurementHistocompatibility TestingBone MarrowPrognosisPostoperative ComplicationsSkin TransplantationLiver FailureMesenchymal Stem Cell TransplantationFetal Tissue TransplantationCells, CulturedFeasibility StudiesLeukemiaThalidomideTransplantation, HeterologousVincristineProspective StudiesTissue TransplantationBone Marrow CellsHematopoiesisLymphomaCell SeparationBlood Component RemovalLeukemia, Myeloid, AcuteGenetic TherapyPrednisoneStem CellsKanamycin KinaseWaiting ListsHistocompatibilityNeoplasm, ResidualCorneal TransplantationAntibodies, MonoclonalMyelodysplastic SyndromesCyclosporineT-LymphocytesTacrolimusAntineoplastic Agents, AlkylatingColony-Forming Units Assay